SEC Form 4 · accession 0000919574-17-004473
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Broadfin Healthcare Master Fund Ltd
10% Owner
Broadfin Capital, LLC
10% Owner
Kevin Kotler
10% Owner
Period of report
May 19, 2017
Accepted (ET)
May 22, 2017 · 1:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 19, 2017 | X | 729,500 | $7.50 | A | 5,184,942 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Put Option (obligation to buy)F1 | $7.50 | May 19, 2017 | X | 7,295 | D | May 19, 2017 | May 19, 2017 | Common Stock | 729,500 | 0 | D |
Explanation of responses
- F1The Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Each of Broadfin Capital, LLC, Broadfin Healthcare Master Fund, Ltd. and Kevin Kotler disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and affirmatively disclaim being a "group" for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.